Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment
Xingyi Pan, Lei Zheng
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 9, pp. 940-953
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
Uttpal Anand, Abhijit Dey, Arvind K. Singh Chandel, et al.
Genes & Diseases (2022) Vol. 10, Iss. 4, pp. 1367-1401
Open Access | Times Cited: 785
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Enyong Dai, Zhi Zhu, Shudipto Wahed, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 194
The current knowledge concerning solid cancer and therapy
Masoud Najafi, Jamal Majidpoor, Heidar Toolee, et al.
Journal of Biochemical and Molecular Toxicology (2021) Vol. 35, Iss. 11
Closed Access | Times Cited: 93
Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy
Jenniffer Linares, Juan A. Marín‐Jiménez, Jordi Badia-Ramentol, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 79
Enriched cancer stem cells, dense stroma, and cold immunity: Interrelated events in pancreatic cancer
Keywan Mortezaee
Journal of Biochemical and Molecular Toxicology (2021) Vol. 35, Iss. 4
Closed Access | Times Cited: 79
Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy
Cai Zhang, Yuan Hu, Weihua Xiao, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 9, pp. 2083-2100
Open Access | Times Cited: 69
Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy
Mengjiao Zhou, Minjian Yuan, Meng Zhang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113825-113825
Open Access | Times Cited: 58
Emerging Epigenetic‐Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment
Jiaxin Zhang, Leaf Huang, Guangbo Ge, et al.
Advanced Science (2023) Vol. 10, Iss. 7
Open Access | Times Cited: 27
Activation of the cGAS-STING pathway by a mitochondrial DNA-targeted emissive rhodium(iii) metallointercalator
Yue Zheng, Xiaoxiao Chen, Dongyang Zhang, et al.
Chemical Science (2023) Vol. 14, Iss. 25, pp. 6890-6903
Open Access | Times Cited: 23
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
X. Xia, Zongxin Yang, Qisi Lu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Myeloid-derived suppressor cells (MDSC): When good intentions go awry
Maria Dulfary Sanchez‐Pino, Matthew J. Dean, Augusto C. Ochoa
Cellular Immunology (2021) Vol. 362, pp. 104302-104302
Open Access | Times Cited: 55
H3K36 trimethylation-mediated biological functions in cancer
Xiao Chu, Tao Fan, He Tian, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 45
Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma
Xingyi Pan, Jiaojiao Zhou, Qian Xiao, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 43
The CTCF/LncRNA‐PACERR complex recruits E1A binding protein p300 to induce pro‐tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating PTGS2 expression
Yihao Liu, Xuelong Wang, Youwei Zhu, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 2
Open Access | Times Cited: 32
Combination of epidrugs with immune checkpoint inhibitors in cancer immunotherapy: From theory to therapy
Ruoyu Guo, Jixia Li, Jinxia Hu, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110417-110417
Open Access | Times Cited: 18
Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances
Tingrui Zhang, Zongguang Tai, Fengze Miao, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 372-396
Closed Access | Times Cited: 8
Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer
Can Huang, Juan Iovanna, Patricia Santofimia‐Castaño
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4970-4970
Open Access | Times Cited: 37
Clonal hematopoiesis is associated with improved survival in patients with metastatic colorectal cancer from the FIRE-3 trial
Christopher Maximilian Arends, Savvina Dimitriou, Arndt Stahler, et al.
Blood (2021) Vol. 139, Iss. 10, pp. 1593-1597
Open Access | Times Cited: 35
Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy
Giasemi C. Eptaminitaki, Nora Wolff, Dimitris Stellas, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3313-3313
Open Access | Times Cited: 34
M2 Macrophage Co-Expression Factors Correlate With Immune Phenotype and Predict Prognosis of Bladder Cancer
Yutao Wang, Kexin Yan, Jianfeng Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 30
Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors
Giuseppe Schepisi, Caterina Gianni, Maria Concetta Cursano, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors
Sayani Patra, Naveed Elahi, Aaron Armorer, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 26
Role of Epigenetics in Pancreatic Ductal Adenocarcinoma
Somnath Pandey, Vineet K. Gupta, Shweta Lavania
Epigenomics (2023) Vol. 15, Iss. 2, pp. 89-110
Open Access | Times Cited: 10
Epigenetic modulation by oncolytic viruses: Implications for cancer therapeutic efficacy
Muhammad Haris Sultan, Qi Zhang, Hao Jin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189270-189270
Closed Access
AC074117.1/miR-193a-3p axis regulates the malignant progression of uterine corpus endometrial carcinoma via the m6A-related gene ALKBH5
Zhong Ding, Fu Lirong, Qian Zhu, et al.
The American Journal of the Medical Sciences (2025)
Closed Access
Page 1 - Next Page

Scroll to top